长模块化非骨水泥股骨柄重建转移性股骨病变的结局
本研究评估长非骨水泥股骨柄(Restoration Modular Revision Hip System Plasma stem)在205例转移性骨病患者中的结局,平均随访45个月,2年和5年再干预概率均为0.010,无因松动行股骨翻修,总体需再次手术并发症率8%。
要点
- 长非骨水泥股骨柄2年和5年再干预概率均为0.010(95%CI 0.000-0.025)。
- 无患者因松动需股骨翻修,3例因假体周围骨折再干预。
- 总体需再次手术并发症率8%(16/205)。
核心结论
- 长非骨水泥股骨柄在转移性骨病中展现良好的短期至中期生存率,无因松动行股骨翻修,并发症率相对较低。
研究设计与样本
- 回顾性分析2008年1月至2025年12月前瞻性收集的三级转移性骨病服务中心数据库,共205例患者接受长非骨水泥股骨柄重建。
主要发现
- 手术指征包括病理性骨折46例(22%)和有骨折风险病变159例(78%)。
- 平均随访45个月(12-131),140例(68%)死亡,平均术后20个月(0.1-128)。
- 股骨头中心至最远端股骨转移灶平均距离126 mm(5-369)。
- 以死亡为竞争风险,2年再干预概率0.010(95%CI 0.000-0.025),死亡概率0.507(95%CI 0.436-0.577)。
- 5年再干预概率0.010(95%CI 0.000-0.025),死亡风险0.703(95%CI 0.629-0.776)。
关键数值与推荐
- 主要终点为股骨假体失败再干预,排除深部感染和/或不稳定再干预。
- 总体需再次手术并发症率8%(16/205),其中3例再干预为股骨假体失败(均为假体周围骨折)。
临床怎么用
- 长非骨水泥股骨柄可作为特定有症状髋周骨转移患者的合适选择。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Cemented arthroplasty has previously been recommended for treating metastatic bone disease (MBD) around the hip. However, cementing has disadvantages, including restricted femoral component length, loosening due to disease progression, and bone cement implantation syndrome (BCIS). A long uncemented implant spanning the whole femur could negate these disadvantages; however, there is a paucity of data regarding their use. Our aim was to assess the outcomes of a long uncemented femoral component in MBD. METHODS: A total of 205 patients with MBD underwent femoral reconstruction using the Restoration Modular Revision Hip System Plasma stem between January 2008 and December 2025. They were identified from the prospectively collected database of a tertiary MBD service. Any patient with symptomatic bone metastases involving the acetabulum or femur, with completed or impending pathological fracture, were included. The primary endpoint was reintervention for femoral implant failure, with exclusion of reintervention for deep infection and/or instability. RESULTS: Indications for surgery included pathological fracture (46 of 205; 22%) or lesions at risk of fracture (78%; n = 159). The mean follow-up was 45 months (12 to 131). A total of 140 patients (68%) died during the study period (mean 20 months (0.1 to 128) postoperatively). The mean distance from the centre of the femoral head to the most distal femoral metastasis was 126 mm (5 to 369). Using death as a competing risk, two-year probability of reintervention was 0.010 (95% CI 0.000 to 0.025) and probability of death was 0.507 (95% CI 0.436 to 0.577). At five years, probability of reintervention was 0.010 (95% CI 0.000 to 0.025) and the risk of death was 0.703 (95% CI 0.629 to 0.776). Overall complication rate requiring further surgery was 8% (16 out of 205) with three reinterventions for femoral implant failure (all periprosthetic femoral fractures). CONCLUSION: This implant demonstrates promising short- to mid-term survivorship, with no patient requiring femoral revision for loosening and a comparatively low complication rate. A long uncemented femoral component may be an appropriate option in selected patients presenting with symptomatic bone metastases around the hip.
引用
- Downie S, Kennedy M, Farhan-Alanie OM, et al. Outcomes of a long modular uncemented femoral stem for reconstruction in metastatic femoral disease. Bone Joint J. 2026. PMID: 42966365. doi:10.1302/0301-620X.108B11.BJJ-2026-0320.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。